Keywords: sandimmune, gains, new, indication, usa, food, drug
SANDIMMUNE GAINS NEW INDICATION IN USA
Article | 07 December 1992
The US Food and Drug Administr-ation's Dermatalogic Drugs Advi-sory Committee has approved Sandoz' immunosuppresive Sandimmune (ciclosporin) for the short-term treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
